Previous Article | Next Article 
Applied and Environmental Microbiology, January 2000, p. 23-28, Vol. 66, No. 1
0099-2240/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Purification and Partial Characterization of a
Murein Hydrolase, Millericin B, Produced by Streptococcus
milleri NMSCC 061
M.
Beukes,1
G.
Bierbaum,2
H.-G.
Sahl,2 and
J. W.
Hastings1,*
School of Molecular and Cellular Biosciences,
University of Natal, Pietermaritzburg, Scottsville, South
Africa,1 and Institute for Medical
Microbiology and Immunology, University of Bonn, D-5300 Bonn, Federal
Republic of Germany2
Received 24 May 1999/Accepted 28 September 1999
 |
ABSTRACT |
Streptococcus milleri NMSCC 061 was screened for
antimicrobial substances and shown to produce a bacteriolytic cell wall
hydrolase, termed millericin B. The enzyme was purified to homogeneity
by a four-step purification procedure that consisted of ammonium sulfate precipitation followed by gel filtration, ultrafiltration, and
ion-exchange chromatography. The yield following ion-exchange chromatography was 6.4%, with a greater-than-2,000-fold increase in
specific activity. The molecular weight of the enzyme was 28,924 as
determined by electrospray mass spectrometry. The amino acid sequences
of both the N terminus of the enzyme (NH2 SENDFSLAMVSN) and
an internal fragment which was generated by cyanogen bromide cleavage
(NH2 SIQTNAPWGL) were determined by automated Edman
degradation. Millericin B displayed a broad spectrum of activity
against gram-positive bacteria but was not active against
Bacillus subtilis W23 or Escherichia coli ATCC
486 or against the producer strain itself. N-Dinitrophenyl derivatization and hydrazine hydrolysis of free amino and free carboxyl
groups liberated from peptidoglycan digested with millericin B followed
by thin-layer chromatography showed millericin B to be an endopeptidase
with multiple activities. It cleaves the stem peptide at the N terminus
of glutamic acid as well as the N terminus of the last residue in the
interpeptide cross-link of susceptible strains.
 |
INTRODUCTION |
Most eubacteria are mechanically
stabilized by the shape-determining peptidoglycan, which consists of
polysaccharide chains that are connected by short peptides. Expansion
of the bacterial cell wall during growth and splitting of the septum
prior to cell separation require enzymes that cleave some of the
existing covalent bonds within the peptidoglycan sacculus. These
enzymes are collectively known as peptidoglycan hydrolases
(24). Some have been characterized as
N-acetylmuramidases, N-acetylglucosaminidases,
N-acetylmuramyl-L-alanine amidases,
endopeptidases, and transglycosidases (10). Most
peptidoglycan hydrolases have been characterized as bacteriolytic
enzymes by in vitro studies (29). Lysostaphin, which is
active against Staphylococcus aureus, is one such enzyme. It
has been suggested that lysostaphin may function catabolically to
release nutrients from other staphylococci in the environment, with the
producer cell being protected by a specific immunity protein (12,
18). The lytic effect of lysostaphin results from a direct attack
on the integrity of the staphylococcal cell wall, specifically bringing about cleavage of the pentaglycine cross-link between the stem peptides
of individual peptidoglycan subunits (4).
Zoocin A, a bacteriolytic cell wall hydrolase produced by
Streptococcus zooepidemicus 4881, like lysostaphin, cleaves
bonds within the peptide moiety of peptidoglycan (26).
Zoocin A has been shown to inhibit the growth of all
Streptococcus pyogenes strains and all S. zooepidemicus strains other than 4881 itself (14). Both
enzymes, lysostaphin and zoocin A, possess a catalytic domain in the
N-terminal portion and a substrate recognition domain in the C-terminal
region. The catalytic domains also have considerable sequence
similarity (25).
The oral streptococcus Streptococcus milleri NMSCC 061 inhibits the growth of a variety of bacterial species. In this article, we report the purification and mode of action of millericin B, produced
by S. milleri NMSCC 061. We show that the mode of action is
lytic, that lysis occurs as a direct result of the interaction of
millericin B with the cell wall, and that millericin B cleaves the
peptide moiety of susceptible peptidoglycan.
 |
MATERIALS AND METHODS |
Bacterial strains.
Stock cultures were stored in tryptone
soy broth (TSB) (Oxoid) at
70°C as a 30% glycerol suspension.
Working cultures were maintained on blood agar plates and subcultured
every 2 weeks at 37°C.
Purification of millericin B.
The purification of millericin
B involved a four-step procedure which included ammonium sulfate
precipitation, gel filtration, ultrafiltration, and ion-exchange
chromatography. Batch cultures (2 × 2.5 liters) of S. milleri NMSCC 061 were grown in TSB at 30°C for 24 h. The
cells were removed from the culture by centrifugation at
8,000 × g for 10 min at 4°C. Millericin B was
recovered from the supernatant by the addition of ammonium sulfate to
75% saturation, precipitation on ice for 6 h, and collection of
the precipitate by centrifugation at 16,000 × g for 20 min. The pellet was dissolved in 30 ml of 1 M NaCl-20 mM phosphate
buffer (pH 7.0). This preparation was applied to a Sephadex G-75 column
(2.5 by 56 cm; Pharmacia), equilibrated, and run at 1 ml/min in 1 M
NaCl-20 mM phosphate buffer (pH 7.0). A sequence of 8-ml fractions was
collected and assayed for millericin B activity. Active fractions were
pooled and concentrated (30×) to a volume of 10 ml in an
ultrafiltration chamber (Amicon) through a YM 10 membrane (Millipore)
with a 10,000 molecular weight cutoff limit. The sample volume was
adjusted to 300 ml with 20 mM phosphate buffer (pH 7.0) and refiltered. This was repeated several times to remove the NaCl from the sample. The
sample was then applied to an SP-Sepharose HP column (1.6 by 10 cm;
Pharmacia). The column was preequilibrated with 20 mM phosphate buffer
(pH 7.0). A gradient of 0 to 90% buffer B (1.5 M NaCl in 20 mM
phosphate, pH 7.0) applied over a period of 50 min was used to elute
millericin B initially. The active fractions were pooled,
rechromatographed, and separated under near-isocratic conditions (1.5 M
NaCl) until a single active peak was obtained. The gradient for the
second elution was from 80 to 85% buffer B over the same time as for
the initial separation. This peak was collected as one fraction,
lyophilized, and stored at 4°C until it was required. The purity of
millericin B was assessed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) by the method of Laemmli (15)
with 12% discontinuous gels and a Mini-Protean II electrophoresis
system (Bio-Rad, Richmond, Calif.). Analysis by mass spectrometry was
conducted with a model API III quadruple mass spectrometer equipped
with an IonSpray source (Sciex, Thornhill, Canada) at the Center for
Mass Spectroscopy, University of Stellenbosch, South Africa. The mass
spectrometry analysis indicated that millericin B was pure. All further
analysis was done with the purified substance.
Purified millericin B was subjected to cyanogen bromide (CNBr) cleavage
to generate internal fragments. The sample was solubilized in 50 µl
of 70% formic acid. A crystal of CNBr was added, and the reaction tube
was flushed with nitrogen upon closing. After 12 h of incubation
at room temperature in the dark, the formic acid was evaporated under a
vacuum. The digest was solubilized in 6 M guanidine-HCl-0.1 M Tris, pH
8.5, and 0.1 M dithiothreitol and resolved by reverse-phase
high-performance liquid chromatography (HPLC). The N-terminal amino
acid sequence was obtained with a model 491 Procise automated sequencer
(Perkin-Elmer Applied BioSystems).
Preparation of cell walls.
Crude cell walls from
Micrococcus luteus ATCC 46898 were prepared from overnight
cultures grown in TSB at 30°C. The cells were collected after
centrifugation at 8,000 × g for 10 min and resuspended
in 20 mM phosphate buffer (pH 7.0). This suspension was incubated for
10 min in a boiling-water bath and centrifuged at 16,000 × g for 15 min (4°C). The pellet was washed twice with 20 mM
phosphate buffer (pH 7.0) and resuspended in a minimal volume of the
same buffer. This suspension was incorporated into agar plates and used
for activity assays. Purified trypsinized cell walls were prepared from
M. luteus and S. aureus NMSCC 133 as previously
described (21). Teichoic acids were extracted by hydrolysis
with 70% HF for 3 h at 0°C (16). HF was neutralized by addition of 6 N KOH, and the cell walls were washed 10 times with
distilled water. Cell walls tended to aggregate and had to be
resuspended by thorough ultrasonification (Virsonic 60; Virtis Company
Inc., Gardiner, N.Y.) after each washing. A suspension of the cell
walls in a polypropylene tube was sonicated for 5 min at 60 W output to
homogeneity or until aggregation was no longer observed. Glass beads
were added to the suspension to facilitate resuspension. They were
assayed for purity by hydrolysis and reverse-phase HPLC of amino acids
and amino sugars after derivatization with o-phthaldialdehyde (20).
Activity assay.
Agar plates containing crude cell wall
extracts from M. luteus were used to assay for millericin B
activity. An aliquot of 20 µl was placed in each prepared well,
incubated at 30°C overnight, and checked for zones of lysis. The
activity of millericin B was estimated by using twofold dilutions of
the test preparations. The inhibitory concentration (defined as
activity units [AU] per milliliter) of millericin B was given as the
reciprocal of the highest twofold dilution to give a distinct zone of
clearing. The activity spectrum for millericin B against several
gram-positive bacteria (S. aureus NMSCC 133, Staphylococcus simulans 22, M. luteus ATCC 46898, Bacillus subtilis W23, Lactococcus lactis ATCC 8756, Listeria monocytogenes ATCC 2457, and
Streptococcus agalactiae ATCC 2305) was determined by using
the spot-on-lawn assay (13).
Renaturing SDS-PAGE (Zymograms).
SDS-polyacrylamide gels
(12% [wt/vol] acrylamide) containing 0.2% (wt/vol) lyophilized
M. luteus cell walls as a substrate were used for the
detection of lytic activity. Upon completion of electrophoresis, the
gels were soaked for 45 min in 250 ml of distilled water at room
temperature with gentle agitation. The gels were then transferred to
250 ml of renaturation buffer (25 mM Tris-HCl [pH 7.5] containing
0.1% Triton X-100 and 10 mM MgCl2) and incubated with
gentle rotation at 37°C for 16 h. The bands with lytic activity
were observed as clear in the opaque gel. To enhance detection of the
lytic bands, the gels were stained for 3 h in 0.1% methylene blue
in 0.01% KOH and destained in distilled water. Samples were mixed 1:1
(vol/vol) with sample buffer at final concentrations of 1% SDS, 10%
glycerol, 1 mM EDTA, 0.0025% (wt/vol) bromophenol blue, 5%
-mercaptoethanol, and 60 mM Tris-HCl (pH 6.5). The samples were
heated for 10 min at 100°C and applied to the gel. Molecular weight
standards (Promega) were run on the same gel, removed, and stained separately.
Appearance of N-acetylamino sugars and free amino
groups in soluble fragments during lysis of bacterial cell walls.
Purified M. luteus cell walls (0.3 mg) were digested, at
30°C, with purified millericin PB (<1 µg/ml) in 20 mM phosphate
buffer, pH 7.01. M. luteus cell walls digested with lysozyme
under the same conditions were used as a control. Reaction mixtures
were centrifuged, and the supernatant was dried under vacuum and
redissolved in 1% K2B7O4. The
appearance of reduced sugars was assayed by the Morgan-Elson test as
previously described (10). The appearance of free amino
groups was determined with Sanger reagent as previously described
(12).
Determination of the N-terminal amino acids liberated.
Purified M. luteus, S. aureus, and S. milleri NMSCC 051 (nonproducer) cell walls (0.3 mg) were digested
overnight with millericin B as described above. Undigested cell walls
were harvested at 16,000 × g for 10 min, and the
supernatant was lyophilized. Lyophilized samples were resuspended in
100 µl of 1% (wt/vol) K2B7O4, 10 µl of fluorodinitrobenzene reagent was added, and the mixture was incubated at 60°C for 30 min. After acidification with concentrated HCl (50 µl) the N-dinitrophenyl (DNP) derivatives of free
amino acids were extracted three times with ether (100 µl). The
residual ether was evaporated at 60°C. The samples were then
hydrolyzed for 6 h at 95°C. The DNP derivatives of the
N-terminal amino acids were extracted three times with ether, and
residual ether was evaporated, dried under vacuum, and redissolved in
0.05 M NH3 and chromatographed on thin-layer plates of
silica gel G (Merck). Free C termini of amino acids were detected by
DNP-hydrazine derivatization followed by thin-layer chromatography. The
plates were first developed with solvent A (n-butanol-1%
ammonia [wt/vol], 1:1; upper phase) at room temperature. After being
dried under a stream of cold air, the plates were developed with
solvent B (chloroform-methanol-acetic acid, 85:14:1; single phase) at
2°C.
Bactericidal action of millericin B on M. luteus ATCC
46898 and S. aureus NMSCC 133 cells.
Suspensions of
log-phase cells of M. luteus and S. aureus were
centrifuged, washed twice, and resuspended in 20 mM phosphate buffer
(pH 7.0) to an optical density at 600 nm (OD600) of 0.5. Aliquots of suitable dilutions taken at different time intervals were
plated on TSB agar plates, and the number of CFU was recorded after
18 h of growth.
 |
RESULTS |
Purification of millericin B.
The purification stages of
millericin are shown in Table 1.
Millericin B is secreted into the supernatant of a growing culture up
to a level of approximately 40 AU/ml. Optimal recovery of activity was
during the mid-log phase of growth. The first step of purification involved ammonium sulfate precipitation. Activity was recovered from
the 70% ammonium sulfate fraction at approximately 7.68 × 104 AU. Considerable loss of activity was noticed during
the gel filtration step (results not shown). The addition of 1 M NaCl to the running buffer increased the recovery of millericin activity by
80-fold, from 26.8 to 2,146.4 AU/mg. After the gel filtration step, the
sample was diluted in 20 mM phosphate and reconcentrated by
ultrafiltration by passing it several times through a membrane with a
cutoff value of 10 kDa. This step served to both desalt the sample and
concentrate the active protein. Repetitive ultrafiltration did not
result in any significant loss of millericin activity. After
ion-exchange chromatography, millericin did not elute as a single peak
but rather as part of a broad peak. The active fractions were pooled,
desalted by ultrafiltration, and reseparated with a near-isocratic
gradient within the elution range of millericin (80 to 85% B). This
resulted in the elution of millericin B as a single peak. The purity of
this peak was assessed by SDS-PAGE (Fig.
1) and found to contain a single band
with an estimated molecular mass of 28 kDa. Activity was linked to this
band by using renaturation SDS-PAGE with gels containing purified
M. luteus cell walls (Fig. 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Stepwise purification of the bacteriolytic enzyme
millericin from the culture supernatant of S. milleri
NMSCC 061
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Polyacrylamide (12%) gel electrophoresis of
purified millericin. Lanes: i, mid-range molecular weight standards
(Promega); ii, purified millericin after ion-exchange chromatography.
(B) Gel slice of a 12% acrylamide zymogram containing 0.1% M. luteus cell walls stained with 0.1% methylene blue in 0.01% KOH
following renaturation of millericin PB in 0.1% Triton X-100 and 10 mM
MgCl2. (C) Electrospray mass spectrometry of millericin B
after ion-exchange chromatography.
|
|
Inhibitory activity of millericin B.
The range of inhibitory
activity of millericin B against gram-positive bacteria was determined
by an agar plate assay. Millericin B was added to wells in agar plates
containing crude cell walls of the indicator cells. Activity was
detected against several gram-positive bacteria tested. These included
L. monocytogenes, S. agalactiae, L. lactis, and a nonproducing S. milleri strain, NMSCC
051. In contrast, B. subtilis was resistant to the action of
millericin B. Escherichia coli, the only gram-negative
bacterium tested, was not susceptible to millericin activity even when
5 mg of millericin B/ml was used. The diameter of the lytic zones produced in M. luteus growth was double that when other
indicator cell walls were used.
N-terminal amino acid sequencing.
The amino-terminal amino
acid sequence of purified millericin B was determined by automated
Edman degradation. The first 12 amino acid residues were as follows:
NH2-Ser-Glu-Asn-Asp-Phe-Ser-Leu-Ala-Met-Val-Ser-Asp. CNBr
cleavage allowed us to obtain the sequence of the first 10 residues of
an internal fragment by automated Edman degradation. The sequence
obtained was as follows: Ser-Ile-Gln-Thr-Asn-Ala-Pro-Trp-Gly-Leu.
Effect of millericin B on the viability of M. luteus
ATCC 46898 cultures.
The addition of millericin B to
stationary-phase M. luteus cultures resulted in an immediate
decrease in the viable count (Fig. 2)
compared with a culture that received milliQue (MQ) water. The
viability of M. luteus decreased by 50% within the first 20 min of incubation. After 100 min of incubation, no viable cells were
recovered.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of millericin B on the growth of M. luteus ATCC 46898. Symbols: , control (addition of MQ water);
, test (addition of millericin).
|
|
Mode of action.
Millericin B was tested for the hydrolysis of
the glycan bond between the N-acetylmuramic acid and
N-acetylglucosamine repeating subunits of peptidoglycan by
the Morgan-Elson test (10). The liberation of free reducing
sugars was monitored photometrically. An increase in the liberation of
reducing sugars was detected in the presence of lysozyme when M. luteus peptidoglycan was used as a substrate (Fig.
3A). There was no significant increase in the liberation of reducing sugars in the presence of millericin B. Substrate in the presence of 20 mM phosphate buffer was used as a
control. In all cases, the OD585 reported is the mean value of triplicate experiments performed.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Liberation of free reducing sugars from the cell
walls of M. luteus ATCC 46898 after digestion with a cell
wall-degrading enzyme, analyzed by the Morgan-Elson test
(12). Symbols: , cell walls digested with lysozyme; ,
cell walls digested with millericin B; , cell wall in the presence
of 20 mM phosphate buffer (pH 7.0). (B). Liberation of free amino
groups from the digestion of M. luteus ATCC 46898 cell walls
with millericin B by N-dinitrophenol (DNP) derivatization
(12). Symbols: , cell walls digested with millericin B;
, cell walls digested with lysozyme; , cell walls in the presence
of 20 mM phosphate buffer (pH 7.0).
|
|
The detection of endopeptidase activity was done by a colorimetric
assay with N-dinitrophenyl derivatization (10).
M. luteus peptidoglycan digested with millericin B showed an
increase in the liberation of free amino groups (Fig. 3B). Controls
contained substrate but no enzyme and showed no significant change in
absorbance, demonstrating that the rise in absorbance in the test was
due to the activity of millericin B. As a negative control, M. luteus peptidoglycan was digested with lysozyme and tested for the
liberation of free amino groups. There was no significant increase in
OD405, indicating that no free amino groups were being liberated.
Thin-layer chromatography showed that a possible cleavage site for
millericin B activity in M. luteus peptidoglycan was the glutamic acid of the stem peptide and the N terminus of the alanine within the interpeptide bridge (Fig. 4).
Similar results were obtained for S. aureus and an S. milleri strain. In contrast to these results, no cleavage was
shown against the S. milleri NMSCC 061 producer strain.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 4.
Fragments of the primary structure, stem peptide, and
interpeptide cross bridge of peptidoglycans found in S. aureus (i), M. luteus (ii), and S. milleri
(iii). A and B, cleavage sites of millericin B as determined by DNP
derivatization and DNP-hydrazine derivatization.
|
|
 |
DISCUSSION |
The purification of peptidoglycan hydrolases usually involves
extracting the enzymes from intact cells by using a high concentration of salts and affinity chromatography with resins with covalently linked peptidoglycan (3). However, S. milleri
NMSCC 061 secretes millericin B directly into the supernatant. This
simplified the purification because a single precipitation step with
ammonium sulfate enabled us to harvest 38% of the total amount of
millericin present in the supernatant. During the early stages of
purification, millericin B activity could be masked by the presence of
cellular proteins and medium components. The possibility of its binding to the carbohydrate moiety of the gel matrix may explain the lack of
activity in the eluting fractions. The addition of NaCl possibly reduces these interactions. Reverse-phase HPLC of the active fractions obtained after gel filtration was unsuccessful. The use of an SP-Sepharose ion-exchange column linked to an HPLC system gave more
satisfactory results. The elution of millericin B from this column was
done under very-high-salt conditions. We were able to purify millericin
B to homogeneity and detect its activity on an SDS-PAGE renaturation
gel. Comparison of the first 10 amino acids as well as the sequence
obtained from the internal fragment to existing protein sequences in
the databases (SWISSPROT, BLAST, and NCBI) revealed no significant
sequence similarity to any known proteins.
The antimicrobial activity of millericin B occurs by cleaving bonds in
the peptide moiety of the peptidoglycan of susceptible organisms.
Lysostaphin-treated S. aureus cells show a rapid reduction in both viable count and OD (22). M. luteus
cultures treated with millericin B showed simultaneous loss of
viability, suggesting that as with lysostaphin, lysis occurred as a
direct result of millericin B activity against the cell wall.
Peptidoglycan is insoluble as a result of the extensive cross-linking
of the subunits. Hydrolysis of sufficient cross-links will bring about
solubilization of the cell wall and consequent lysis (27).
Several methods exist to detect the enzymatic nature of the hydrolysis
reaction, most of which measure the increase in OD of a particular
component released via a colorimetric assay (10). The
application of these assays in the present study enabled the activity
of millericin B to be measured. Millericin B was characterized as an
endopeptidase, cleaving bonds within the peptide moiety of
peptidoglycan. Several strains were sensitive to millericin B, and all
had the same stem peptide sequence (L-Ala,
D-Glu, L-Lys, D-Ala) but different
cross-links in their peptidoglycans. In contrast, millericin B-treated
B. subtilis and E. coli cells showed no loss in
viability, even after 5 mg of enzyme/ml was added and the incubation periods were prolonged. This could indicate that resistance is due to
the absence of a specific cleavage site because the cross-links in both
these organisms are of the A1
type and they both have
diaminopimelic acid substituted for lysine in their stem peptides
(23). Modification of peptidoglycan can also affect sensitivity to peptidoglycan hydrolases. B. cereus
peptidoglycan is resistant to lysozyme because of the unacetylated
amino groups on the majority of its glucosamine residues, and it can be
converted to a lysozyme-sensitive form by acetylation with acetic
anhydride (2, 11). Conversely, the lysozyme resistance of
the peptidoglycans of other organisms is due to O-acetylation of
aminosugars, and these peptidoglycans can be made lysozyme sensitive by
de-O-acetylation with a dilute base (5, 9, 19). Accessory
cell wall polymers, such as teichoic acids or lipoteichoic acids, can
also affect the susceptibility of bacteria to a number of peptidoglycan
hydrolases (1, 3, 6, 8). The millericin B producer strain,
S. milleri NMSCC 061, did not show any susceptibility to
millericin B. For most bacteriocins, including lysostaphin, the
producer strain is protected from the effects of its own bacteriocin
through the action of a specific immunity factor (7, 12,
28). The lysostaphin resistance gene (epr) encodes a
protein that specifies the modification of peptidoglycan cross bridges
in S. simulans 22 and S. aureus (7).
The millericin B producer strain may also utilize a similar mechanism
to protect itself from millericin B.
Analysis of the cell wall digests of susceptible peptidoglycan showed
two possible cleavage sites (Fig. 4). The first site is at the alpha
amino group of glutamic acid (Fig. 5)
This cleavage site was present on all types of peptidoglycan tested.
The second site appears to be located within the interpeptide
bridge. Cleavage occurred at the alpha amino group of the C-terminal
residue in the interpeptide bridge. This phenomenon of multiple
enzymatic activities has also recently been linked to the murein
hydrolase of the staphylococcal phage
11 (17). Deletion
mutant analysis showed that the enzyme had both
D-alanyl-glycyl endopeptidase and
N-acetylmuramyl-L-alanyl amidase activities. The
phage
11 enzyme consists of three domains, an endopeptidase domain,
an amidase domain, and a cell wall-targeting domain. In contrast, lysostaphin only cuts at the alpha amino group of a glycine residue, indicating that lysostaphin only cuts within the interpeptide bridge
and not the stem peptide of S. aureus peptidoglycan
(22).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Amino acid residues detected after digestion of
peptidoglycan from three bacterial strains, DNP derivatization was used
to detect free N termini and DNP-hydrazine derivatization was used for
the C termini. A representative thin-layer chromatograph of cell walls
from M. luteus appears as an example. Mix, mixture of
standard amino acids that occur in the cell wall of M. luteus; M.l., M. luteus.
|
|
 |
ACKNOWLEDGMENTS |
This work was partially supported by grants from the Foundation
for Research and Development of South Africa and the BONFOR program of
the Medical Faculty, University of Bonn.
We also thank M. van der Merwe of the Biochemistry Department,
University of Stellenbosch, for the mass spectrometry analysis and R. Chauhan of the Molecular Biology Unit, University of Natal, for the
amino acid sequencing analysis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: School of
Molecular and Cellular Biosciences, University of Natal, P.O. Box X01,
Scottsville 3209, South Africa. Phone: 27 331 260 5434. Fax: 27 331 260 5435. E-mail: Hastings{at}gene.unp.ac.za.
 |
REFERENCES |
| 1.
|
Amako, K.,
A. Umeda, and K. Murata.
1982.
Arrangement of peptidoglycan in the cell wall of Staphylococcus spp.
J. Bacteriol.
150:844-850[Abstract/Free Full Text].
|
| 2.
|
Araki, Y.,
T. Nakatani,
K. Wakayama, and E. Ito.
1972.
Occurrence of N-nonsubstituted glucosamine residues in peptidoglycan of lysozyme resistant cell walls of Bacillus cereus.
J. Biol. Chem.
247:6312-6322[Abstract/Free Full Text].
|
| 3.
|
Bierbaum, G., and H.-G. Sahl.
1987.
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase.
J. Bacteriol.
169:5452-5458[Abstract/Free Full Text].
|
| 4.
|
Browder, H. P.,
W. A. Zygmunt,
J. R. Young, and P. A. Tavorina.
1965.
Lysostaphin: enzymatic mode of action.
Biochem. Biophys. Res. Commun.
19:383-389[CrossRef][Medline].
|
| 5.
|
Clarke, A. J.
1993.
Extent of peptidoglycan O-acetylation in the tribe Proteae.
J. Bacteriol.
175:4550-4553[Abstract/Free Full Text].
|
| 6.
|
Cleveland, R. F.,
J.-V. Holtje,
A. J. Wicken,
A. Tomasz,
L. Daneo-Moore, and G. D. Shockman.
1975.
Inhibition of bacterial wall lysins by lipoteichoic acids and related compounds.
Biochem. Biophys. Res. Commun.
67:1128-1135[CrossRef][Medline].
|
| 7.
|
DeHart, H. P.,
H. E. Heath,
L. S. Heath,
P. A. LeBlanc, and G. L. Sloan.
1995.
The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.
Appl. Environ. Microbiol.
61:1475-1479[Abstract].
|
| 8.
|
Fischer, W.,
P. Rösel, and H. U. Koch.
1981.
Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus.
J. Bacteriol.
146:467-475[Abstract/Free Full Text].
|
| 9.
|
Ghuysen, J.-M., and J. L. Strominger.
1963.
Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. II. Separation and structure of disaccharides.
Biochemistry
2:1119-1125.
|
| 10.
|
Ghuysen, J.-M.,
D. J. Tripper, and J. L. Strominger.
1966.
Enzymes that degrade cell walls.
Methods Enzymol.
8:685-699.
|
| 11.
|
Hayashi, H.,
Y. Araki, and E. Ito.
1973.
Occurrence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme.
J. Bacteriol.
113:592-598[Abstract/Free Full Text].
|
| 12.
|
Heath, H. E.,
L. S. Heath,
J. D. Nitterauer,
K. E. Rose, and G. L. Sloan.
1989.
Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus.
Biochem. Biophys. Res. Commun.
160:1106-1109[CrossRef][Medline].
|
| 13.
|
Jack, R. W., and J. R. Tagg.
1992.
Factors affecting production of the group A streptococcus bacteriocin SA-FF22.
J. Med. Microbiol.
36:132-138[Abstract].
|
| 14.
|
James, S. M., and J. R. Tagg.
1988.
A search within the genera Streptococcus, Enterococcus, and Lactobacillus for the organisms inhibitory to mutans streptococci.
Microb. Ecol. Health Dis.
1:153-162.
|
| 15.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 16.
|
Lipkin, D.,
B. E. Philips, and J. W. Abrell.
1969.
The action of hydrogen fluoride on nucleotides and other esters of phosphorus (V) acids.
J. Org. Chem.
34:1539-1547[CrossRef].
|
| 17.
|
Navarre, W. W.,
H. Ton-That,
K. F. Faull, and O. Schneewind.
1999.
Multiple enzymatic activities of the murein hydrolase from staphylococcal phage 11.
J. Biol. Chem.
274:15847-15856[Abstract/Free Full Text].
|
| 18.
|
Recsei, P. A.,
A. D. Gruss, and R. P. Novick.
1987.
Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans.
Proc. Natl. Acad. Sci. USA
84:1127-1131[Abstract/Free Full Text].
|
| 19.
|
Rosenthal, R. S.,
J. K. Blundell, and H. R. Perkins.
1982.
Strain-related differences in lysozyme sensitivity and extent of O-acetylation of gonococcal peptidoglycan.
Infect. Immun.
37:826-829[Abstract/Free Full Text].
|
| 20.
|
Sahl, H.-G.,
M. Grossgarten,
W. R. Widger,
W. A. Cramer, and H. Brandis.
1985.
Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin.
Antimicrob. Agents Chemother.
27:836-840[Abstract/Free Full Text].
|
| 21.
|
Sahl, H.-G.,
C. Hahn, and H. Brandis.
1985.
Interaction of the staphylococcin-like peptide Pep-5 with cell walls and isolated cell wall components of gram-positive bacteria.
Zentlbl. Bakteriol. Hyg. A.
260:197-205.
|
| 22.
|
Schindler, C. A., and V. T. Schuhardt.
1964.
Lysostaphin: a new bacteriolytic agent from the staphylococcus.
Proc. Natl. Acad. Sci. USA
51:414-421[Free Full Text].
|
| 23.
| Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic
implications. 36:407-477.
|
| 24.
|
Shockman, G. D., and J.-V. Holtje.
1994.
Microbial peptidoglycan (murein) hydrolases, p. 131-166.
In
J.-M Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science, Amsterdam, The Netherlands.
|
| 25.
|
Simmonds, R. S.,
W. Simpson, and J. R. Tagg.
1997.
Cloning and sequence analysis of zoocin A, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin.
Gene
189:255-261[CrossRef][Medline].
|
| 26.
|
Simmonds, R. S.,
L. Pearson,
R. C. Kennedy, and J. R. Tagg.
1996.
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881.
Appl. Environ. Microbiol.
62:4536-4541[Abstract].
|
| 27.
|
Strominger, J. L., and J. M. Ghuysen.
1967.
Mechanism of enzymatic bacteriolysis.
Science
156:213-221[Free Full Text].
|
| 28.
|
Tagg, J. R.,
A. S. Dajani, and L. W. Wannamaker.
1976.
Bacteriocins of gram positive bacteria.
Microbiol. Rev.
40:722-756[Free Full Text].
|
| 29.
|
Ward, J. B., and R. Williamson.
1984.
Bacterial autolysins: specificity and function, p. 159-166.
In
C. Nombela (ed.), Microbial cell wall synthesis and autolysins. Elsevier Science Publishers B. V., Amsterdam, The Netherlands.
|
Applied and Environmental Microbiology, January 2000, p. 23-28, Vol. 66, No. 1
0099-2240/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fujita, K., Ichimasa, S., Zendo, T., Koga, S., Yoneyama, F., Nakayama, J., Sonomoto, K.
(2007). Structural Analysis and Characterization of Lacticin Q, a Novel Bacteriocin Belonging to a New Family of Unmodified Bacteriocins of Gram-Positive Bacteria. Appl. Environ. Microbiol.
73: 2871-2877
[Abstract]
[Full Text]
-
Heng, N. C. K., Ragland, N. L., Swe, P. M., Baird, H. J., Inglis, M. A., Tagg, J. R., Jack, R. W.
(2006). Dysgalacticin: a novel, plasmid-encoded antimicrobial protein (bacteriocin) produced by Streptococcus dysgalactiae subsp. equisimilis. Microbiology
152: 1991-2001
[Abstract]
[Full Text]
-
Kenny, J. G., McGrath, S., Fitzgerald, G. F., van Sinderen, D.
(2004). Bacteriophage Tuc2009 Encodes a Tail-Associated Cell Wall-Degrading Activity. J. Bacteriol.
186: 3480-3491
[Abstract]
[Full Text]
-
Nilsen, T., Nes, I. F., Holo, H.
(2003). Enterolysin A, a Cell Wall-Degrading Bacteriocin from Enterococcus faecalis LMG 2333. Appl. Environ. Microbiol.
69: 2975-2984
[Abstract]
[Full Text]
-
Beukes, M., Hastings, J. W.
(2001). Self-Protection against Cell Wall Hydrolysis in Streptococcus milleri NMSCC 061 and Analysis of the Millericin B Operon. Appl. Environ. Microbiol.
67: 3888-3896
[Abstract]
[Full Text]